Structure-Based Design for High-Hanging Vaccine Fruits

被引:6
|
作者
Back, Jaap W. [2 ]
Langedijk, Johannes P. M. [1 ]
机构
[1] Crucell Innovat & Discovery Lab, Leiden, Netherlands
[2] Pepscan Therapeut, Lelystad, Netherlands
来源
ADVANCES IN IMMUNOLOGY , VOL 114: SYNTHETIC VACCINES | 2012年 / 114卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; HIV-1; GP120; BROAD NEUTRALIZATION; CRYSTAL-STRUCTURES; MOUTH-DISEASE; BINDING MODE; GP41; EPITOPE;
D O I
10.1016/B978-0-12-396548-6.00002-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although vaccines have proven life saving against a myriad of infectious diseases, various pathogens have remained refractory to prophylaxis of their host by active immunization. New insights in the three dimensional (3D) structure, domain organization and dynamics of viral and bacterial surface proteins can guide the design of effective vaccines in several ways. In this review we highlight recent developments in structure-based vaccine design that are aimed at stabilization of native conformations and focusing immune response to conserved epitopes. Detailed 3D structures of pathogen surface proteins provide knowledge on how to minimize complex antigens or how to redesign the surface of an immunogen in order to induce only relevant neutralizing antibodies against a broad range of serotypes. Structure - based vaccines with reduced complexity and broad efficacy could greatly enhance the number of people that might benefit from the therapies that are developed.
引用
收藏
页码:33 / 50
页数:18
相关论文
共 50 条
  • [31] Structure-based drug design
    Stroud, RM
    FASEB JOURNAL, 1997, 11 (09): : A839 - A839
  • [32] Structure-based drug design
    Henry, CM
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (23) : 69 - +
  • [33] Assessment of structure-based design
    Kuntz, ID
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 1 - COMP
  • [34] ASSESSMENT OF STRUCTURE-BASED DESIGN
    KUNTZ, ID
    FASEB JOURNAL, 1995, 9 (06): : A1252 - A1252
  • [35] Structure-based inhibitor design
    Craig, SP
    Eakin, AE
    VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58, 2000, 58 : 149 - +
  • [36] STRUCTURE-BASED MOLECULAR DESIGN
    KUNTZ, ID
    MENG, EC
    SHOICHET, BK
    ACCOUNTS OF CHEMICAL RESEARCH, 1994, 27 (05) : 117 - 123
  • [37] Structure-based design of agrochemicals
    Walter, MW
    NATURAL PRODUCT REPORTS, 2002, 19 (03) : 278 - 291
  • [38] Structure-based drug design
    Kubinyi, H
    CHIMICA OGGI-CHEMISTRY TODAY, 1998, 16 (10) : 17 - 22
  • [39] STRUCTURE-BASED DRUG DESIGN
    MONTGOMERY, JA
    NIWAS, S
    CHEMTECH, 1993, 23 (11) : 30 - 37
  • [40] Structure-based drug design
    Murcko, MA
    Caron, PR
    Charifson, PS
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 297 - 306